Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
54.00
-1.56 (-2.81%)
Nov 17, 2026, 3:04 PM CST

SHE:002653 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
2,5761,3861,0561,169775.39575.11
Trading Asset Securities
176-150.13160.06--
Cash & Short-Term Investments
2,7521,3861,2061,329775.39575.11
Cash Growth
95.92%14.94%-9.23%71.37%34.82%-53.41%
Accounts Receivable
1,0981,0331,077883.9803.79569.97
Other Receivables
26.1225.3340.3546.7947.1478.5
Receivables
1,1241,0581,117930.69850.93648.47
Inventory
330.44306.77271.61281.29346259.95
Prepaid Expenses
-10.0922.55---
Other Current Assets
83.7372.87112.53100.0281.3264.9
Total Current Assets
4,2912,8342,7302,6412,0541,548
Property, Plant & Equipment
861.31853.21917.09996.041,0741,137
Long-Term Investments
153.38177.99146.99232.46422.17381.19
Other Intangible Assets
2,0051,5181,277751.23708.33682.47
Long-Term Deferred Tax Assets
204.84204.7177.23148.24126.0883.57
Long-Term Deferred Charges
541.3957.531,1071,4271,233822.42
Other Long-Term Assets
957.97465.62443.95457.37430.15350.51
Total Assets
9,0157,0116,7986,6536,0485,005

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
247.83165.85195.89208.99242.44301.4
Accrued Expenses
130.3261.19190.48200.09136.68120.63
Short-Term Debt
229.779.95242.5799.98484.69452.18
Current Portion of Long-Term Debt
1,337880.74728.41833.59295.4325.78
Current Portion of Leases
-7.8410.277.416.648
Current Income Taxes Payable
86.028.925.4916.0816.11.71
Current Unearned Revenue
60.0516.7220.8714.6126.9628.44
Other Current Liabilities
127.01146.03174.23123.23279.64279.98
Total Current Liabilities
2,2181,5671,5681,5041,4891,518
Long-Term Debt
670.71,002925854.681,320452.41
Long-Term Leases
31.129.554.1410.854.5210.91
Long-Term Unearned Revenue
125.35134.7795.06108.4798.52102.54
Long-Term Deferred Tax Liabilities
12.999.623.774.012.531.11
Other Long-Term Liabilities
---0.38--
Total Liabilities
3,0582,7232,5962,4822,9142,085

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,1411,1201,1201,1141,0761,077
Additional Paid-In Capital
2,3411,085953.57853.38100.8297.62
Retained Earnings
2,5552,1362,1802,2101,8071,733
Treasury Stock
-52.34-56.66-80.94-9.15-24.44-38.31
Comprehensive Income & Other
-26.235.7740.5511.8676.41-26.82
Total Common Equity
5,9594,2904,2134,1803,0362,842
Minority Interest
-2.01-2-11.09-9.3697.6878.27
Shareholders' Equity
5,9564,2884,2024,1713,1332,920
Total Liabilities & Equity
9,0157,0116,7986,6536,0485,005

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,2691,9801,9101,8072,1111,249
Net Cash (Debt)
483.79-593.2-704.22-477.74-1,336-674.16
Net Cash Growth
------
Net Cash Per Share
0.43-0.53-0.62-0.44-1.25-0.63
Filing Date Shares Outstanding
1,1341,1551,1591,0481,0361,091
Total Common Shares Outstanding
1,1341,1551,1591,0481,0361,091
Working Capital
2,0731,2671,1621,137565.0930.32
Book Value Per Share
5.253.713.633.992.932.61
Tangible Book Value
3,9532,7722,9373,4292,3272,159
Tangible Book Value Per Share
3.492.402.533.272.251.98
Buildings
-930.28931.33965.52922.14931.62
Machinery
-818.33789.01748.62709.94677.15
Construction In Progress
-0.66.735.8797.988.54